Jan 05, 2026
Qualcomm Turns ‘Physical AI’ From Buzzword Into Reality

At CES 2026, Qualcomm Inc. (NASDAQ:QCOM) aggressively positioned itself as the central architect of the “connected edge,” providing full-stack ecosystems for IoT, robotics, and automotive sectors. Unifying IoT and Next-Gen Robotics Qualcomm is consolidating the fragmented Internet of Things market…

Jan 05, 2026
Incyte Study Shows Lymphoma Drug Combo Slows Aggressive Blood Cancer

Incyte Corporation (NASDAQ:INCY) on Monday shared topline results from the pivotal Phase 3 frontMIND trial of tafasitamab (Monjuvi/Minjuvi) combo as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL). The trial evaluated tafasitamab and lenalidomide in…

Jan 05, 2026
L3Harris Sells Majority Stake In Space Propulsion Unit

L3Harris Technologies, Inc. (NYSE:LHX) announced on Monday that it has agreed to sell a controlling interest in its Space Propulsion and Power Systems business to AE Industrial Partners, a private investment firm focused on aerospace and national security technologies. The…

Jan 05, 2026
Neumora’s Alzheimer’s Agitation Drug Shows Early Promise

Neumora Therapeutics, Inc. (NASDAQ:NMRA) on Monday shared results from its Phase 1b signal-seeking study of NMRA-511 for Alzheimer’s disease (AD) agitation. NMRA-511 demonstrated a clinically meaningful effect size in people with AD agitation. In the study, NMRA-511 demonstrated a favorable…

Jan 05, 2026
Crinetics Experimental Pill Slashes Hormones In Rare Adrenal Disease Trial

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) on Monday shared topline results from the fourth cohort of its Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant for CAH and adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome. CAH is a genetic disease that affects the…

Jan 05, 2026
Zenas BioPharma Touts Phase 3 Win, But Stock Crashes

Zenas BioPharma Inc. (NASDAQ:ZBIO) stock is trading lower on Monday after the company released results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD). IgG4-RD is an immune system disorder where the body creates excess IgG4…

Jan 05, 2026
Phillips 66 Makes Strategic UK Bet With Lindsey Refinery Asset Acquisition

Phillips 66 (NYSE:PSX) stock rose Monday, supported by company-specific developments and broader optimism around potential shifts in global oil investment flows. • Phillips 66 stock is trading at elevated levels. What’s next for PSX stock? Investor sentiment was also buoyed after…

Jan 05, 2026
What’s Going On With Tower Semiconductor Stock Monday?

Tower Semiconductor Ltd. (NASDAQ:TSEM) stock rose Monday after the company announced a strategic collaboration with LightIC Technologies to manufacture silicon photonics–based Frequency-Modulated Continuous-Wave (FMCW) LiDAR sensors, targeting automotive, robotics, and emerging "Physical AI" applications. The stock initially rose following the…